| | Scenario 1 (Healthy, stable). ∖“A 50-year-old healthy woman presents with MELENA and is hemodynamically STABLE (BP 120/80, HR 65). There is NO evidence of a volume deficit on clinical exam. BELOW what hemoglobin level (in g/L) would you transfuse red blood cells in this patient?∖” | Scenario 2 (Cardiac disease, stable). ∖“A 50-year-old man with triple-vessel coronary artery disease presents with MELENA and is hemodynamically STABLE (BP 120/80, HR 65). There is no evidence of a volume deficit on clinical exam. The patient denies having any chest pain or dyspnea, and his ECG and troponin are unremarkable. BELOW what hemoglobin level would you transfuse red blood cells in this patient?∖” |
| | Scenario 3 (Cirrhosis, stable). ∖“A 65-year-old patient with decompensated cirrhosis presents with HEMATEMESIS and is hemodynamically STABLE (BP 100/60, HR 85). There is no evidence of a volume deficit on clinical exam. BELOW what hemoglobin level would you transfuse red blood cells in this patient?∖” | Scenario 4 (Warfarin therapy, unstable). ∖“A 65-year-old woman with hypertension and atrial fibrillation who is taking Warfarin (INR 2.5) presents with MELENA, and is hemodynamically UNSTABLE (BP 90/60, HR 115) There is evidence of a volume deficit on clinical exam and the patient is being resuscitated with intravenous crystalloid. BELOW what hemoglobin level would you transfuse red blood cells in this patient?∖” |
|
|
